UT Southwestern Medical Center Kidney Cancer Program

UT Southwestern Medical Center Kidney Cancer Program

Comments

Cure for Flu

It is known that ethanol (Hard Liquor) kills corona virus on surfaces.
© I found a cure for flu. Put drops of Whiskey (Jack Daniels Old Number 7) in nose to keep nose clear at first sign of flu. Use Whiskey nose drops to keep nose clear & you don't get sick. Normally you sneeze & nose clogs up. Virus will try to clog nose up, use Whiskey nose drops to keep nose clear and you don’t get sick. Bourbon & Whisky have the magnitude, if you go to sleep, nose clogs and it gets down in lungs, I guess you can drink Bourbon to solve the lung infection problem. I would guess any hard liquor would work. You may have water down 180 proof.
Sincerely Robert Texas Bailey Please respond if you verify cure or Post on Twitter or Facebook your results.
Hard Liquor Alcohol Kills Corona Virus on Surface. Reference https://www.healthline.com/health/does-alcohol-kill-germs#what-else-works
Many cough and flu remedies contain alcohol, Nyquil, Vicks Formula 44D, Romilar III cough syrup and Hall’s cough drops.
Other Alcohol Research: https://arxiv.org/ftp/arxiv/papers/2003/2003.12444.pdf?fbclid=IwAR1XtVPmaqW38pKdGNThnMEe2GxvGDtfqnTBuutk5VfKaw7A7dV8uV1Vtrc
Link to page https://1drv.ms/w/s!AvNu_9uUe2zdgkP76OZZcEOWcWCX
Hii...I Joy..
Live-in Bangladesh...
I want to sell a kidney?Because one has to do the operation! Math talk will help. May Kidney
Congratulations to UT Southwestern Medical Center Kidney Cancer Program, the lab #JoeysWings supported since 2017! A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the FDA, providing a new treatment for patients with familial kidney cancer!

Belzutifan is a medication used for the treatment of von Hippel–Lindau disease-associated renal cell carcinoma. Studies by the scientists from UTSW led to the first clinical trial of belzutifan led by the UTSW Kidney Cancer Program. The clinical trial showed that the drug was well-tolerated and active.

What an exciting milestone for patients with inherited forms of kidney cancer! VHL syndrome happens with children too.

https://bit.ly/3sEMcOp
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted here at UT Southwestern Medical Center Kidney Cancer Program received approval from the U.S. Food and Drug Administration providing a new treatment for patients with familial kidney cancer. Learn more: https://bit.ly/3DaUoLj.
The 6th annual #joeysrun in Dallas, TX will be on July 31st to benefit UT Southwestern Medical Center Kidney Cancer Program. Joey's Wings is excited to partner with DASH running group and Plano Pacers Running Club again this year. All funds raised goes to the research on translocation renal cell carcinoma which affects children and young adults. Register at https://thedriven.net/cs/planopacers/july-2021-charity-run

A big thank you to Michelle Liu from Harker High School at the Bay Area, who designed this very unique logo!

Let’s rock the heat!
Proud of our work featured in the magazine of breakthroughs in kidney cancer from UT Southwestern Medical Center Kidney Cancer Program. #JoeysWings has raised $200,000 to advance research in translocation renal cell carcinoma at UTSW. The seed funding provided by Joey’s Wings was instrumental in securing 1.1 million from Cancer Prevention and Research Institute of Texas to advance tRCC research.

Our 5th annual Joey’s Run is coming on July 31st in Dallas! That’s how we rock the hot weather! We will continue to raise fund for research in tRCC which impacts children and young adults.
Today, the KCP lost a staunch advocate, Tony Towler. Tony pioneered the KCP Patient Advocacy Program. He spent countless hours in clinic for many years, often in the company of Merlinda, easing the fears of others patients and sharing stories. He shaped not only the Patient Advocacy Program but the identity of the KCP as a program that seeks to foster a sense of community, where patients feel they belong, where they feel accompanied by other patients in a similar predicament or caregivers. Tony was one of a kind. With his and Merlinda’s passing, the KCP has lost two pioneers and staunch advocates.
On this #worldkidneycancerday, we recognize the hard work of kidney cancer researchers and thank them for their efforts in finding a cure.

Meet Dr. Gopinath Prakasam, a postdoctoral fellow in the Brugarolas Lab at UT Southwestern Medical Center Kidney Cancer Program. Dr. Prakasam's research has led to the development of a successful mouse model for translocation renal cell carcinoma, a rare and aggressive form of pediatric kidney cancer that took Joey’s life. Developing a reliable model is often the most challenging and time consuming part of the research process and plays a pivotal role in drug discovery.

#JoeysWings has funded the study on translocation RCC at UTSW since 2017. Because of your dedication and persistence to help us, we could continue to fund lifesaving research on childhood kidney cancer.
"It's the first study in #kidneycancer where we now have data to help us understand how the destination of the tumor could effect how it behaves & how patients respond to various therapies." Payal Kapur, M.D. Click to read more on this recent study by researchers at UT Southwestern Medical Center Kidney Cancer Program. 👉 https://bit.ly/2VAzUq1

PC: UT Southwestern Medical Center
A study from UT Southwestern Medical Center Kidney Cancer Program researchers suggests kidney cancers that spread to the pancreas have a different biology from those that spread elsewhere. Read more.
Kidney Cancer Month reminds us of how grateful we are for the UT Southwestern Medical Center Kidney Cancer Program and employees like Gopi Prakasam, Ph.D. Passionate about biology from an early age, Dr. Prakasam studies pediatric kidney cancer – work that he describes as "life-changing, potentially life-saving, and incredibly rewarding." He has participated in the KCP's pivotal research on treating translocation carcinoma, a rare and highly aggressive kidney cancer that affects children.
More than 60,000 people in the U.S. are diagnosed with kidney cancer each year. Researchers at UT Southwestern Medical Center Kidney Cancer Program are looking at the role immunotherapy can play in treating some of those patients more efficiently.

Learn more about how being named a V Foundation Scholar in 2007 and then receiving a Translational Grant in 2018 impacted this groundbreaking research: https://www.v.org/2020/under-the-microscope-a-new-technology-for-a-better-treatment/

Kidney Cancer Program, est. 2013 The American Cancer Society estimates that in 2014, 63,920 people were diagnosed with kidney cancer and 13,860 people died from the disease.

At UT Southwestern Harold C. Simmons Comprehensive Cancer Center, we are committed to the development of new therapies and the search for a cure. In 2013, UT Southwestern Medical Center formalized its commitment to the care of kidney cancer patients and research on kidney cancer by officially instituting a Kidney Cancer Program (KCP). The KCP includes more than 20 physicians, many of whom are reno

Operating as usual

11/25/2021

Wishing everyone a very Happy Thanksgiving!🍂🦃

Wishing everyone a very Happy Thanksgiving!🍂🦃

UT Southwestern and UT Dallas to break ground on $120 million joint bioengineering research facility 11/15/2021

UT Southwestern and UT Dallas to break ground on $120 million joint bioengineering research facility

https://www.dallasnews.com/business/health-care/2021/11/15/ut-southwestern-and-ut-dallas-to-break-ground-on-120-million-joint-bioengineering-research-facility/?utm_source=pushly

UT Southwestern and UT Dallas to break ground on $120 million joint bioengineering research facility The University of Texas Southwestern Medical Center and the University of Texas at Dallas will break ground Monday on a new $120 million biomedical...

DeBerardinis receives 2021 Paul Marks Prize for Cancer Research - CT Plus - UT Southwestern 11/12/2021

DeBerardinis receives 2021 Paul Marks Prize for Cancer Research - CT Plus - UT Southwestern

Congratulations to Dr. Ralph DeBerardinis on receiving the 2021 Memorial Sloan Kettering Paul Marks Prize for Cancer Research. A Howard Hughes Medical Institute Investigator and a leader in cancer metabolism, Dr. DeBerardinis studies how kidney cancers use nutrients. We are privileged to have him as one of our KCP Co-Leaders.
https://www.utsouthwestern.edu/ctplus/stories/2021/paul-marks-prize.html

DeBerardinis receives 2021 Paul Marks Prize for Cancer Research - CT Plus - UT Southwestern Ralph DeBerardinis, M.D., Ph.D., a Professor at UT Southwestern in the Children’s Medical Center Research Institute at UT Southwestern, is one of three researchers awarded the 2021 Memorial Sloan Kettering Paul Marks Prize for Cancer Research.

Timeline Photos 11/11/2021

In honor of those who have served and continue to serve our country, thank you and happy Veterans Day!

On this Veterans Day, thank you to all who have served and continue to serve our country.

UT Southwestern designated founding Rare Disease Center of Excellence 11/06/2021

UT Southwestern designated founding Rare Disease Center of Excellence

Congratulations to UTSW on being nationally recognized as a Center of Excellence for treating rare diseases. Quite an honor. This designation lets patients with rare diseases know they can receive exceptional care here across their entire lifespans - from birth through old age.

UT Southwestern designated founding Rare Disease Center of Excellence UT Southwestern Medical Center has been selected as a Rare Disease Center of Excellence – charter members of an elite network of 31 centers nationally to expand access, and advance care and research for rare disease patients in the United States.

Immunotherapy for Frontline Treatment of Kidney Cancer Has ‘Curative Potential’ 11/05/2021

Immunotherapy for Frontline Treatment of Kidney Cancer Has ‘Curative Potential’

INTERVIEW: Dr. Hans Hammers sits down with CURE magazine to discuss the evolution of immunotherapies for metastatic kidney cancer, the effectiveness of different drug combinations, and the movement toward "triple therapies."

Immunotherapy for Frontline Treatment of Kidney Cancer Has ‘Curative Potential’ An expert discusses how the kidney cancer treatment landscape has changed over the last few years, although the number of options available for patients may make it somewhat confusing to navigate.

11/02/2021

Dr. Tian Zhang begins seeing patients at Simmons Cancer Center this week. Delighted to have her aboard. Learn more about our newest KCP medical oncologist and clinical researcher: https://kcp.utsw.edu/utsw-newsroom/cprit-award-brings-prominent-kidney-cancer-investigator-to-utsw/

Dr. Tian Zhang begins seeing patients at Simmons Cancer Center this week. Delighted to have her aboard. Learn more about our newest KCP medical oncologist and clinical researcher: https://kcp.utsw.edu/utsw-newsroom/cprit-award-brings-prominent-kidney-cancer-investigator-to-utsw/

Photos from UT Southwestern Medical Center Kidney Cancer Program's post 10/21/2021

Thank you to our partner Joey's Wings Foundation for supporting our translational research efforts, specifically our pediatric kidney cancer research. And a special thank you to Yunqi Zhang, a remarkable young man and high school volunteer with Joey's Wings in California, who created his own charitable organization, Flex Kids Culture, and raised $10,000 to support pediatric kidney cancer research at UTSW, as well. Thrilled he was able to make the trip to Dallas to be part of the presentations!

Unusual kidney cancer feature sheds light into how cancers invade and metastasize 10/21/2021

Unusual kidney cancer feature sheds light into how cancers invade and metastasize

How cancer invades and spreads throughout the body is one of its least understood aspects. A newly published study by UTSW Kidney Cancer Program researchers lifts the veil on this process by leveraging a unique aspect of kidney cancer known as tumor thrombus. In doing so, researchers discovered metastasis isn't always driven by the most aggressive cells in the primary tumor.

Unusual kidney cancer feature sheds light into how cancers invade and metastasize How cancers metastasize remains poorly understood. The process begins when cancer cells break off from a tumor and invade blood and lymphatic vessels, the body’s alleyways.

10/07/2021

Never know who you'll see walking through the campus food court. Hao Zhu, M.D., Associate Professor of Internal Medicine and cancer researcher, enjoying a little change of scenery while getting some work done.

Never know who you'll see walking through the campus food court. Hao Zhu, M.D., Associate Professor of Internal Medicine and cancer researcher, enjoying a little change of scenery while getting some work done.

10/06/2021

In a recently published study led by KCP Pathology Co-Leader Payal Kapur, M.D., researchers outline the molecular biology of a newly identified tumor entity which falls in a group of kidney tumors historically difficult to classify due to their overlapping benign and malignant features. bit.ly/Class_LOTtumor

In a recently published study led by KCP Pathology Co-Leader Payal Kapur, M.D., researchers outline the molecular biology of a newly identified tumor entity which falls in a group of kidney tumors historically difficult to classify due to their overlapping benign and malignant features. bit.ly/Class_LOTtumor

10/06/2021

NCI Comprehensive Designation Renewal

It's kind of a big deal. (Only 51 comprehensive cancer centers in the country.)

10/05/2021

Welcome to our newest kidney cancer oncologist and researcher, Dr. Qian (Janie) Qin.
https://profiles.utsouthwestern.edu/profile/124594/qian-qin.html

Welcome to our newest kidney cancer oncologist and researcher, Dr. Qian (Janie) Qin.
https://profiles.utsouthwestern.edu/profile/124594/qian-qin.html

09/24/2021

This month, we honor the women physicians whose achievements have helped redefine medicine and transform care. Thank you to our KCP specialists who move kidney cancer care forward and bring life-changing relief to our patients.

This month, we honor the women physicians whose achievements have helped redefine medicine and transform care. Thank you to our KCP specialists who move kidney cancer care forward and bring life-changing relief to our patients.

Photos from UT Southwestern Medical Center Kidney Cancer Program's post 09/24/2021

Capping off National Postdoc Appreciation Week with an informal breakfast taco break. A wonderful opportunity to see some of the many scholars from the UTSW labs supporting kidney cancer research and say "Thank you!" So appreciative for all they do.

09/23/2021

This North Texas Giving Day, help support the development of groundbreaking kidney cancer research by donating to the Kidney Cancer Program: https://www.utsouthwestern.edu/departments/kidney-cancer/support/.

This North Texas Giving Day, help support the development of groundbreaking kidney cancer research by donating to the Kidney Cancer Program: https://www.utsouthwestern.edu/departments/kidney-cancer/support/.

Photos from UT Southwestern Simmons Comprehensive Cancer Center's post 09/15/2021

We're paws-itive you're going to love the newest member of our cancer center team.

National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation 09/07/2021

National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation

DID YOU KNOW... Having 'Comprehensive' in our name - the Harold C. Simmons Comprehensive Cancer Center - is kind of a big deal. It represents the highest federal rating a cancer center can achieve and is considered the gold standard. There are only 51 designated comprehensive cancer centers in the U.S. Our award-winning Kidney Cancer Program is founded on the combined strengths of the Simmons Comprehensive Cancer Center and UT Southwestern, one of the country's preeminent academic medical centers.

National Cancer Institute renews Simmons Cancer Center’s prestigious comprehensive designation The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.

09/03/2021

Meet Sanford Jeames, D.H.A., a new member of the Kidney Cancer Program's Patient Advocate Council. A health educator, Dr. Jeames is passionate about equity in cancer care. His research interests are in health promotion, cancer prevention, and lifestyle interventions, with a focus on underserved populations. He volunteers his time with several national and international cancer-related organizations, sharing information with researchers about how cancer impacts patients and communities culturally. Welcome to the KCP! We're so happy to have you.

Meet Sanford Jeames, D.H.A., a new member of the Kidney Cancer Program's Patient Advocate Council. A health educator, Dr. Jeames is passionate about equity in cancer care. His research interests are in health promotion, cancer prevention, and lifestyle interventions, with a focus on underserved populations. He volunteers his time with several national and international cancer-related organizations, sharing information with researchers about how cancer impacts patients and communities culturally. Welcome to the KCP! We're so happy to have you.

08/27/2021

A Third Dose? Weighing in on COVID-19 Booster Shots

Wondering if you should get a third vaccine? Unsure of the difference between a third dose and a booster? This short, informative video answers these and other pressing #COVID19 vaccine questions.

08/26/2021

We are pleased to welcome two new members to our External Scientific Advisory Board: Elizabeth Plimack, M.D., M.S., and Rana McKay, M.D. Dr. Plimack is Chief of Genitourinary Medical Oncology at Fox Chase Cancer Center in Philadelphia, and Dr. McKay is with the Moores Cancer Center at the University of California - San Diego.

We are pleased to welcome two new members to our External Scientific Advisory Board: Elizabeth Plimack, M.D., M.S., and Rana McKay, M.D. Dr. Plimack is Chief of Genitourinary Medical Oncology at Fox Chase Cancer Center in Philadelphia, and Dr. McKay is with the Moores Cancer Center at the University of California - San Diego.

Timeline Photos 08/26/2021

Learn about belzutifan's amazing two decade journey at UT Southwestern - from discovery to development to use.

A first-in-kind kidney cancer drug, belzutifan, developed from lab and translational studies at the UT Southwestern Simmons Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration. Learn more: https://bit.ly/3sEMcOp

Timeline Photos 08/26/2021

Wonderful news for our kidney cancer patients!

Welcome to Andrew Wang, M.D., who joins us as A. Kenneth Pye Professor in Cancer Research and our new Associate Vice Chair for Research. Dr. Wang's research focuses on the application of biomedical engineering to cancer research. Clinically, he specializes in the treatment of GU and GI cancers. We're so happy to have you at UTSW!

Follow Dr. Wang on Twitter! @andyzwang

08/18/2021

ICYMI - More exciting treatment announcements this month for kidney cancer patients! Along with the new HIF-2a inhibitor, belzutifan, being greenlighted, the combination therapy of lenvatinib plus pembrolizumab - an immune checkpoint inhibitor - also received FDA approval. bit.ly/FDA-LenvatinibPembrolizumab

ICYMI - More exciting treatment announcements this month for kidney cancer patients! Along with the new HIF-2a inhibitor, belzutifan, being greenlighted, the combination therapy of lenvatinib plus pembrolizumab - an immune checkpoint inhibitor - also received FDA approval. bit.ly/FDA-LenvatinibPembrolizumab

FDA approves belzutifan for cancers associated with von Hippel-Lindau 08/14/2021

FDA approves belzutifan for cancers associated with von Hippel-Lindau

📢📢 NEW DRUG ANNOUNCEMENT📢📢

Exciting news for patients! Belzutifan approval marks a paradigm shift in the treatment of kidney cancer toward a highly targeted drug with minimal side effects. Also marks the introduction of a new class of drugs known as HIF-2a inhibitors which were discovered at UT Southwestern. Learn more about UTSW's role in this important drug development: bit.ly/video_HIF2research-trials_UTSW

FDA approves belzutifan for cancers associated with von Hippel-Lindau FDA approves belzutifan for cancers associated with von Hippel-Lindau disease Oncology News Burst

08/12/2021

KCP researchers Payal Kapur, Srinivas Malladi, and Qing Zhang joined advocates from across the country this week to meet with members of Congress on the importance of kidney cancer research funding as part of #DistrictDays.

KCP researchers Payal Kapur, Srinivas Malladi, and Qing Zhang joined advocates from across the country this week to meet with members of Congress on the importance of kidney cancer research funding as part of #DistrictDays.

08/08/2021

Meet our newest kidney cancer investigator, Dr. Chen Yao. https://www.utsouthwestern.edu/departments/kidney-cancer/news-and-videos/

Meet our newest kidney cancer investigator, Dr. Chen Yao. https://www.utsouthwestern.edu/departments/kidney-cancer/news-and-videos/

Timeline Photos 08/06/2021

NTX hospitalizations are rising at an alarming rate.
Delta is different.
We strongly encourage everyone to get vaccinated.

Based on current behaviors and vaccination rates, our forecast is predicting a substantial increase in hospitalizations related to COVID-19 to levels beyond those observed during last summer's surge. Read more: https://bit.ly/3ioIRzq

Photos from UT Southwestern Medical Center Kidney Cancer Program's post 08/06/2021

Dr. Hans Hammers finding another opportunity to encourage everyone to get the COVID-19 vaccine.

Photos from UT Southwestern Simmons Comprehensive Cancer Center's post 08/06/2021

So exciting watching this being built!

Photos from UT Southwestern Medical Center Kidney Cancer Program's post 08/03/2021

Thank you to everyone who participated this past Saturday in the 5th Annual Joey's Wings Foundation Charity 5k. Appreciate the Plano Pacers Running Club and DASH Running Club for hosting the fundraising event benefiting pediatric kidney cancer research at UTSW. This year's run featured new, streamlined procedures to help support a safe experience for those in attendance.

08/03/2021

We're proud of UTSW's patient-centric culture; the dedication, compassion, and expertise of our caregivers; and the vision of our leadership.

We're proud of UTSW's patient-centric culture; the dedication, compassion, and expertise of our caregivers; and the vision of our leadership.

UT Southwestern among top 25 in nation in eight specialties ranked by U.S. News ‘Best Hospitals’ 07/29/2021

UT Southwestern among top 25 in nation in eight specialties ranked by U.S. News ‘Best Hospitals’

We are honored to be named a "best hospital" nationally in eight specialties, including cancer and urology, by U.S. News and World Report. Not to mention once again being named the No. 1 hospital in Dallas-Fort Worth.

Read more about the stories behind UTSW's rankings - and how we put patients' needs first every day.

UT Southwestern among top 25 in nation in eight specialties ranked by U.S. News ‘Best Hospitals’ UT Southwestern Medical Center ranks among the top 25 hospitals nationally in eight specialties ranging from brain to heart to cancer care, according to the latest U.S. News & World Report’s annual Best Hospitals report.

07/15/2021

Mark your calendars and grab your running shoes...

The 5th Annual Joey's Wings Charity 5K Run/Walk benefitting kidney cancer research at UTSW is July 31, 2021, at Bob Woordruff Park in Plano. Proceeds raised go to Joey's Wings Foundation, a Kidney Cancer Program (KCP) fundraising partner. To date, Joey's Wings has donated more than $200,000 to support KCP research on translocation renal cell carcinoma, a rare and highly aggressive pedriatic kidney cancer. More information and online registration here: https://thedriven.net/cs/planopacers/july-2021-charity-run

Mark your calendars and grab your running shoes...

The 5th Annual Joey's Wings Charity 5K Run/Walk benefitting kidney cancer research at UTSW is July 31, 2021, at Bob Woordruff Park in Plano. Proceeds raised go to Joey's Wings Foundation, a Kidney Cancer Program (KCP) fundraising partner. To date, Joey's Wings has donated more than $200,000 to support KCP research on translocation renal cell carcinoma, a rare and highly aggressive pedriatic kidney cancer. More information and online registration here: https://thedriven.net/cs/planopacers/july-2021-charity-run

ACS CAN and CodeX Lead Project to Expand Cancer Clinical Trial Enrollment Through Improved Technology 07/06/2021

ACS CAN and CodeX Lead Project to Expand Cancer Clinical Trial Enrollment Through Improved Technology

ACS CAN and CodeX Lead Project to Expand Cancer Clinical Trial Enrollment Through Improved Technology The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medica...

Our Story

The American Cancer Society estimates that in 2018, 63,340 people will be diagnosed with kidney cancer and 14,970 people will die from the disease. At UT Southwestern Harold C. Simmons Comprehensive Cancer Center, we are committed to the development of new therapies and the search for a cure.

In 2013, UT Southwestern Medical Center formalized its commitment to the care of kidney cancer patients and research on kidney cancer by officially instituting a Kidney Cancer Program (KCP). The KCP includes more than 20 physicians, many of whom are renowned international leaders in their fields of urology, pediatric oncology, adult oncology, radiation oncology, radiology, and pathology. In addition, more than 40 scientists with their research laboratories are a part of the KCP.

The KCP builds on landmark discoveries made by scientists at UT Southwestern over the last three decades. Drs. Steven McKnight and David Russell discovered HIF-2α, a protein that mediates kidney cancer development. Subsequent studies by Drs. Richard Bruick and Kevin Gardner led to the development of a drug that blocks HIF-2 activity. In addition, DJ Pan, Ph.D., discovered that the TSC1/TSC2 complex regulates TOR, which is the target of two kidney cancer drugs. Years later, James Brugarolas, M.D., Ph.D., discovered mutations in TSC1 in kidney cancer, and the presence of these mutations may identify patients most likely to respond to TOR inhibitors. Finally, recent discoveries by several investigators at UT Southwestern, including Payal Kapur, M.D., determined that there are different subtypes of kidney cancer with different biology and outcomes.

Videos (show all)

Kidney Cancer Program at UT Southwestern Medical Center
Australian native travels 9,000 miles to UT Southwestern Kidney Cancer Program
Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial
CrossFitter tackles stage IV kidney cancer
Why volunteers raise funds for UT Southwestern Kidney Cancer Program
LIVE Q&A with Dr. Hans Hammers and Dr. Vitaly Margulis.
Despite the Odds, Stage IV Kidney Cancer Patient is now cancer free
Seven minute whole-body MRI finds more bone metastases
State-of-the-Art MRI Technology Bypasses Need for Biopsy
Tee Off Fore Kidney Cancer
2017 Kidney Cancer Program Annual Event hosted hundreds
Patient Stories: Harold Wellbaum

Location

Category

Address


6000 Harry Hines Blvd
Dallas, TX
75390

General information

In 2013, UT Southwestern Medical Center formalized its commitment to the care of kidney cancer patients and research on kidney cancer by officially instituting a Kidney Cancer Program (KCP). The KCP includes more than 20 physicians, many of whom are renowned international leaders in their fields of urology, pediatric oncology, adult oncology, radiation oncology, radiology, and pathology. In addition, more than 40 scientists with their research laboratories are a part of the KCP.
Other Hospitals in Dallas (show all)
Medical District Hospital Parking Lot at 2210 Bulter Medical District Hospital Parking Lot at 2210 Bulter
2210 Butler
Dallas, 75235

Medical District parking lot. Privately owned, this is the closest parking to employee, emergency, and trauma entrances at Parkland Memorial Hospital.

E-Clinic Veterinary E-Clinic Veterinary
3337 N Fitzhugh Ave
Dallas, 75204

The Emergency Animal Clinic, Inc. opened its doors for urgent pet care more than 38 years ago.

Premier Cancer Centers - CyberKnife of Dallas Premier Cancer Centers - CyberKnife of Dallas
10425 N Central Expy
Dallas, 75231

Premier Cancer Centers - CyberKnife of Dallas is the premier cancer treatment center in Dallas TX.

Renew Orthopedics Renew Orthopedics
10 Medical Pkwy, Ste 209
Dallas, 75234

Renew Orthopedics is a group of general orthopedic surgeons throughout the Dallas metroplex that specialize in the treatment of sports injuries, joint replacement, hand, wrist, shoulder, knee, hip, hand, extremity, carpal tunnel, foot, and ankle injuries.

North Texas Podiatric Medicine and Surgery Associates North Texas Podiatric Medicine and Surgery Associates
5481 Blair Rd
Dallas, 75231

Our clinic specializes in diabetic foot wounds as well as general podiatric medicine. We conduct research and are involved in FDA trials for new diabetic foot products/medications

Children's Medical Center Dallas Children's Medical Center Dallas
1935 Medical District Drive
Dallas, 75235

UTSW Resident Cosmetic Surgery Clinic UTSW Resident Cosmetic Surgery Clinic
1801 Inwood Rd
Dallas, 75235

The Neuropsychology & Counseling Center, LLC The Neuropsychology & Counseling Center, LLC
Dallas, 75244

Provide neuropsychological evaluations and treatment for a variety of neurologic and psychiatric illnesses to improve quality of life.

SMU ISSS SMU ISSS
Dallas, 75205

The SMU International Student & Scholar Services provides immigration services to students, scholars and professors on F or J visas. Our staff coordinates pre-arrival information, current compliance issues as well as data management

Dallas ENT Group Dallas ENT Group
7777 Forest Ln Ste B432
Dallas, 75230

Dallas ENT Group is a group of board certified otolaryngologists and audiologists located inside Medical City Dallas, conveniently located near the 75 and 635 exchange.

Syam Home Healthcare Syam Home Healthcare
191 S Corinth St Rd
Dallas, 75203

Syam Healthcare provides in-home professional healthcare services by certified and licensed nurses and support staff.

Texas Health Surgery Center Dallas Texas Health Surgery Center Dallas
7150 Greenville Ave. Suite 200
Dallas, 75231

We are committed to Outstanding Patient Care and Clinical Outcomes